Market Closed -
Nasdaq
01:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
21.42
USD
|
+1.09%
|
|
-10.68%
|
+171.48%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
125.1
|
388.7
|
22.3
|
88.03
|
319.7
|
-
|
-
|
Enterprise Value (EV)
1 |
125.1
|
304
|
-15.95
|
88.03
|
102.7
|
319.7
|
319.7
|
P/E ratio
|
-1.94
x
|
-2.92
x
|
-0.47
x
|
-1.28
x
|
-4.15
x
|
-5.12
x
|
-4.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
58.1
x
|
202
x
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
58.1
x
|
202
x
|
EV / EBITDA
|
-
|
-83,39,116
x
|
3,45,718
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-8.42
x
|
0.34
x
|
-
|
-1.47
x
|
-4.1
x
|
-3.12
x
|
FCF Yield
|
-
|
-11.9%
|
291%
|
-
|
-68.2%
|
-24.4%
|
-32.1%
|
Price to Book
|
-
|
4.27
x
|
0.5
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,250
|
4,952
|
4,618
|
11,158
|
15,086
|
-
|
-
|
Reference price
2 |
100.1
|
78.50
|
4.829
|
7.890
|
21.19
|
21.19
|
21.19
|
Announcement Date
|
08/06/21
|
18/03/22
|
08/03/23
|
04/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
5.5
|
1.582
|
EBITDA
|
-
|
-36.46
|
-46.13
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-36.83
|
-51.2
|
-68.86
|
-76.65
|
-85.97
|
-113.2
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-1,563.1%
|
-7,153.35%
|
Earnings before Tax (EBT)
1 |
-
|
-30.64
|
-37.68
|
-64.46
|
-73.05
|
-81.4
|
-112.4
|
Net income
1 |
-31.67
|
-30.64
|
-37.68
|
-64.46
|
-73.05
|
-81.4
|
-108.3
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-1,479.98%
|
-6,844.42%
|
EPS
2 |
-51.70
|
-26.90
|
-10.30
|
-6.180
|
-5.105
|
-4.139
|
-5.170
|
Free Cash Flow
1 |
-
|
-36.11
|
-46.43
|
-
|
-69.99
|
-77.88
|
-102.5
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-1,415.98%
|
-6,479.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/06/21
|
18/03/22
|
08/03/23
|
04/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-12.44
|
-11.87
|
-
|
-17.55
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-10.08
|
-12.08
|
-12.78
|
-11.96
|
-12.71
|
-13.75
|
-13.95
|
-17.83
|
-19.36
|
-17.72
|
-18.41
|
-18.77
|
-19.3
|
-20.03
|
-16.07
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-3.412
|
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-17.44
|
-17.78
|
-18.4
|
-19.45
|
-16.07
|
Net income
1 |
-3.412
|
-9.057
|
-2.207
|
-10.4
|
-11.86
|
-13.21
|
-14.26
|
-16.08
|
-17.54
|
-16.58
|
-17.44
|
-17.78
|
-18.4
|
-19.45
|
-16.07
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.9020
|
-2.500
|
-0.6000
|
-2.900
|
-3.200
|
-3.600
|
-1.600
|
-1.500
|
-1.600
|
-1.500
|
-1.232
|
-1.182
|
-1.212
|
-1.204
|
-0.8300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/11/21
|
18/03/22
|
12/05/22
|
12/08/22
|
10/11/22
|
08/03/23
|
12/05/23
|
11/08/23
|
09/11/23
|
04/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
84.7
|
38.3
|
-
|
217
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-36.1
|
-46.4
|
-
|
-70
|
-77.9
|
-103
|
ROE (net income / shareholders' equity)
|
-
|
-78.3%
|
-71.4%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
18.40
|
9.690
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-29.60
|
-12.60
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2.43
|
0.58
|
0.27
|
0.58
|
0.92
|
1.5
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
16.81%
|
94.47%
|
Announcement Date
|
08/06/21
|
18/03/22
|
08/03/23
|
04/03/24
|
-
|
-
|
-
|
Last Close Price
21.19
USD Average target price
64.17
USD Spread / Average Target +202.82% Consensus |
1st Jan change
|
Capi.
|
---|
| +171.48% | 320M | | +32.36% | 698B | | +26.51% | 568B | | -4.40% | 358B | | +19.46% | 328B | | +3.50% | 283B | | +16.34% | 238B | | +6.68% | 203B | | -9.08% | 198B | | +8.62% | 165B |
Other Pharmaceuticals
|